We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Intermittent Bolus or Continuous Infusion of Proton Pump Inhibitors for Ulcer Bleeding?

Yao-Chun Hsu, MD1; Hwai-Jeng Lin, MD, FACG2
[+] Author Affiliations
1Center for Database Research, School of Medicine, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan
2Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, School of Medicine, Taipei Medical University, Taipei, Taiwan
JAMA Intern Med. 2015;175(3):461. doi:10.1001/jamainternmed.2014.7797.
Text Size: A A A
Published online


To the Editor We read with great interest the article by Sachar et al.1 The authors are to be commended for their thorough literature review and careful analysis. However, several issues may need clarification before jumping to conclusions.

First, how endoscopic therapy might interact with pharmacotherapy to determine outcomes was not addressed. Given that monotherapy with epinephrine injection is suboptimal to achieve hemostasis, it is intriguing to clarify whether the dosage of a proton pump inhibitor (PPI) should differ according to endoscopic treatment, especially when the meta-analysis included 6 studies that allowed injection therapy alone. Another important determinant for recurrent bleeding is the ulcer stigmata because an actively spurting ulcer is much more likely to rebleed. This kind of lesion may require more potent inhibition of gastric acid. In fact, an earlier randomized trial has demonstrated that in patients with active arterial bleeding ulcers, an intermittent PPI dose (intravenous, 40 mg every 8 hours) could not effectively decrease rebleeding compared with histamine receptor antagonist (ranitidine).2 Conceivably, a higher dose of PPI may be indicated in patients at higher risk of rebleeding. A recent randomized trial has actually showed that double dose of oral PPI outperformed the standard dose among the high-risk patients (Rockall scores ≧6) after 3-day PPI infusion.3


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...